Consolidation has precipitated a sharp decline in number of $1bn+ independent specialty chemical companies Buoyed by M&A and resilient profitability, specialty chemical trading multiples continue to outperform and are now […]
Chemicals M&A remains strong and the outlook for 2018 continues to be robust as company profits stay high Number of quality M&A targets decreasing as consolidation gathers speed and more […]
Profit growth is driving chemicals EV/EBITDA trading multiples which have hit an all-time high High tier specialty chemicals and additives companies benefitting most with multiples increasing from c. 10 to […]
2017 chemicals M&A expected to remain well above recent history as companies aggressively target M&A opportunities Businesses continue to divest intermediate chemicals as competition from China rises Analysis shows companies […]
No slowdown in chemicals M&A activity as structural realignment, low growth and strong profits continue to underpin the market Companies are optimizing M&A through additional cost synergies, scale benefits and […]
Chemicals M&A hits an all-time high in 2015 and 2016 looks on track to continue the trend Almost 60 large specialty chemicals transactions greater than $1bn in last five years […]
Oil price analysis demonstrates that the chemical industry has benefitted from high oil prices over the last 20 years Chemical company valuations remain robust despite recent market volatility with many […]
2014 chemicals M&A surged in both volume and value terms reaching a 7-year high Average transaction and trading multiples now both at c. 10 x EBITDA Chemical companies’ increasing profitability […]
Chemicals has been one of the most favored sectors for shareholder activists Chemical companies’ portfolio structures combined with high profitability will continue to be highly attractive to activist investors European […]
Chemical company EBITDA trading multiples indicate high-end specialty chemicals now most fairly valued area M&A advisory boutiques continue to gain ground on the majors and recent court rulings regarding conflicts […]
Larger step-out M&A deals most admired by chemicals industry senior executives and advisors Chemicals M&A volumes continuing the upward trend at the end of 2013 with more larger transactions being […]
2013 H2 proved to be the strongest chemicals M&A market for the last three years Valuations of public chemical companies in US/Europe reached a 15 year high Chemical M&A transaction […]
Shareholder activists increasingly scrutinising portfolio chemical companies with further investments expected A rush of $1bn+ transactions and increasing M&A volumes hitting a high in October 2013 prove chemical M&A is […]
Valuation multiples remain slightly below historical levels but strong company profitability is fuelling higher transaction prices M&A volumes are increasing with a large number of potential transactions coming to the […]
Can a chemical company share price outperform its sub-sector peers? Companies strive to grow revenue and profitability with the aim of increasing their share price and valuation. However, to what […]
Despite macroeconomic uncertainty, chemicals M&A ended 2012 strongly and this should continue in 2013. Fundamental structural change, due to increased activity by Asian and Middle Eastern companies, is impacting the […]
Almost 35% of chemicals M&A transactions currently involve Asia or the Middle East. With this forecast to increase, a wider group of buyers are evaluating a broader range of chemical […]
What drives chemical company valuations? The second Valence Group newsletter focuses on the theme of valuation. After seeing many investment bank presentations with scatter diagrams professing to show barely discernible […]
Welcome to the first issue of the Valence Chemicals M&A Review.It is our aim in these Reviews to deliver some analytical perspectives on the chemicals and materials M&A market and […]